BioSpace News Archive

Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that on February 24, 2020,

Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, announced its financial results for the fourth quarter and full year ended December 31, 2019.

Valencia Technologies Corporation (“Valencia”), a private medical device company, today announced interim efficacy data from the eCoin Pivotal Clinical Trial will be presented at the upcoming Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2020 Annual Meeting to be held from February 25 – 29 in Scottsdale, Arizona

Illumina, Inc. announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products.

Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that it will report fourth quarter and full year 2019 financial and operating results on Thursday, March 5, 2020.

The HIMSS Global Health Conference & Exhibition will proceed as scheduled March 9-13 in Orlando, Fla. As of February 27, 2020, registration is experiencing an upswing of 7 percent over HIMSS19 participation.

Definitive merger agreement with Forte Biosciences announced February 19, 2020

-Biohaven Pharma Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), , today announced results for the fourth quarter and year ended December 31, 2019, in addition to providing an update on the company’s recent activities.

Acceleron Pharma Inc today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2019.